Attached files

file filename
EX-99.1 - PRESS RELEASE 6/17/2011 - PSS WORLD MEDICAL INCpressrelease.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  June 17, 2011
 
PSS WORLD MEDICAL, INC.
(Exact name of Registrant as specified in its charter)
 
Commission File Number:  0-23832
 
Florida
59-2280364
(State or other jurisdiction
(IRS Employer
of incorporation or organization)
Identification Number)
   
4345 Southpoint Blvd.
 
Jacksonville, Florida
32216
(Address of principal executive offices)
(Zip code)
   
   
Registrant’s telephone number, including area code
(904) 332-3000

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 
Item 8.01 Other Events
 
On June 17, 2011, PSS World Medical, Inc. (the “Company”) issued a press release announcing the Company’s Board of Directors authorized the repurchase of up to five percent (5%) of the outstanding shares of the Company’s common stock.  This authorization is in addition to any shares remaining available under existing repurchase programs.  A copy of the press release is furnished as Exhibit 99.1 to this report.


 
Item 9.01 Financial Statements and Exhibits
 
(d) Exhibits
 
99.1  Press release issued June 17, 2011 regarding share repurchase program.

 
 






 

 
 

 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
 
  PSS WORLD MEDICAL, INC.  
         
Date: June 17, 2011
By:
 /s/ David M. Bronson  
    Name: David M. Bronson  
    Title: Executive Vice President and Chief Financial Officer  
         
 
 
 
 

 

EXHIBIT INDEX

 
Exhibit
Number
 
Description
99.1 Press release issued June 17, 2011 regarding share repurchase program.